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Introduction
Porcine somatotropin ( pST) is an anabolic hormone that improves nitrogen retention and reduces lipid accretion rates in pigs (Campbell et al., 1988; Evock-Clover et al., 1992) . Somatotropin also has a role in the function and regulation of the immune system (Weigent, 1996) . Recent studies have shown that somatotropin treatment can augment antibody synthesis in monkeys (LeRoith et al., 1996) and improve host defenses against bacterial infection in mice (Inoue et al., 1995) .
Few studies have been conducted to determine the effects of a disease challenge on the immune responses and growth performance of somatotropin-treated domesticated animals. Somatotropin-treated cattle (Elsasser et al., 1994) exhibited decreased tumor necrosis factor (TNF)-a concentrations following endotoxin challenge. Goff et al. (1991) observed a decrease in antibody response to tetanus toxoid 15 d after immunization of finishing pigs, but not on d 8, 22, or 29. However, they were not trying to induce a disease state. Therefore, the objectives of this study were to determine the effects of an acute endotoxin challenge on the growth performance, carcass accretion rates, and hormone and metabolite concentrations in growing swine treated with somatotropin and to determine whether pST treatment could ameliorate the cachectic response to an endotoxin challenge.
Materials and Methods
Animals. Forty-one crossbred barrows were used to determine the effects of and interactions between recombinant pST and an endotoxin challenge on growth performance, carcass component accretion rates, and serum hormone and metabolite concentrations in growing swine. The pigs were randomly allotted to treatments at a starting weight of 20.1 ± .2 kg. The treatment groups were as follows: 1 ) controls, i.m. injected daily with sterile, nonpyrogenic water from 20 to 55 kg BW, and then slaughtered ( n = 7); 2 ) pST, i.m. injected daily with 100 mg of rpST/kg BW from 20 to 55 kg, and then slaughtered ( n = 9); 3 ) lipopolysaccharide ( LPS) control, no treatment from 20 to 60 kg BW, followed by daily i.v. injections of 10 mL of nonpyrogenic saline for 7 d while being pair-fed to the LPS treatment group ( n = 8); 4 ) LPS, no treatment from 20 to 60 kg BW, followed by daily i.v. injections of 1 mg of LPS (derived from E. coli)/kg BW in 10 mL of nonpyrogenic saline for 7 d ( n = 8); and 5 ) LPS-pST, i.m. injected daily with 100 mg of rpST/kg BW from 20 to 60 kg plus during the week of LPS treatment as described for group 4, and LPS was injected immediately before rpST ( n = 9).
The hypothesis was that the pigs grown to 60 kg and then treated with LPS for 1 wk would lose weight and finish at approximately 55 kg BW. Six additional 20-kg pigs were randomly selected at the beginning of the experiment to be used as a baseline for comparative slaughter purposes. All procedures performed on pigs in this experiment were approved by the Beltsville Area Swine Care and Use Committee.
Pigs were individually penned and fed a common diet (Table 1 ) containing 18% CP, 1.2% lysine, and 3.5 Mcal of DE/kg. Pigs were restrictively fed, initially at 90% of calculated ad libitum intake per kilogram of BW (ARC, 1981) , with access to feed from 0800 to 1200; this reduced access to feed results in less wasting of feed and more accurate feed intake measurements. After 5 wk on trial, feed was increased to 110% of calculated ad libitum intake to maximize feed intake to what the pST-treated pigs would consume, because we have found that the ARC equation underestimates ad libitum feed intake for American swine breeds, and pigs treated with pST during the grower phase do not voluntarily reduce their feed intake. All feed was usually consumed by 1100 to 1200; therefore, feed intake was used to assess general animal health. Pigs were weighed weekly, and feed intake and rpST dosage were adjusted accordingly. Rectal temperatures were obtained from all pigs in the final three treatment groups at 0800 at the time of LPS or buffer injection and again at 1100 on d 7 of LPS or buffer injection.
Somatotropin. The rpST was purchased from
Southern Cross (Toorak, Victoria, Australia) and was supplied as a powder of 50% rpST and 50% bicarbonate buffer. The rpST was reconstituted in sterile, nonpyrogenic water 1 d prior to use. All pigs were injected in the extensor neck muscle between 0800 and 0830 prior to feeding.
Bacterial
Lipopolysaccharide.
The bacterial lipopolysaccharide was purchased from Difco Laboratories (Detroit, MI). The LPS was diluted in sterile, nonpyrogenic saline and was administered i.v. in the vena cava in 10-mL volumes at a dosage of 1 mg/kg BW daily for 7 d.
Blood Collection and Analysis. Blood samples were obtained from each pig by venipuncture in the vena cava just before the pigs were fed at 0800 and again at 1100 at 55 kg BW and on d 7 of LPS treatment. Serum was collected and analyzed for several hormones and metabolites. Insulin and pST were vmeasured by RIA (Steele et al., 1985) . The pST used for iodination and as standards was generously provided through the USDA Animal Hormone Program. Insulin-like growth factor-I was measured by RIA (Ballard et al., 1990) except that 20 mL of pig serum was extracted with 80 mL of PBS and 400 mL of acid-ethanol. This mixture was then neutralized with 200 mL of Tris base. Recombinant human IGF-I ( R & D Systems, Minneapolis, MN) was used as the standard, and rabbit anti-human antiserum (generously provided by GroPep, Adelaide, Australia) was used as the primary antibody. Glucose and serum urea nitrogen ( SUN) were determined using standard laboratory procedures for a CentrifiChem 600 (Baker Instrument, Allentown, PA).
Carcass Accretion. Pigs were stunned by electric shock and then killed by exsanguination. Organ weights were obtained for the heart, liver, kidney, spleen, and thymus. The right side of each carcass was chilled overnight, and standard carcass measurements were recorded. The half-carcass was then ground in entirety and samples frozen for carcass analysis. Standard AOAC (1970) methods were used to determine carcass water, nitrogen, and ash contents. Carcass lipid was extracted and measured gravimetrically (Folch et al., 1957) .
Statistics. Statistical analyses were performed using the GLM procedures of SAS (1985) . Final weight, as a covariate, was included in the model for carcass data for all five treatments, except when organ weights, expressed as a percentage of BW, were included in the model. The covariate was included so comparisons could be made between biological variables obtained after 1 wk of LPS treatment and those obtained at 55 kg BW before endotoxin treatment. The Bonferroni method was used to compare means. Only three treatments were used to analyze the growth performance variables obtained during the week of LPS treatment (Table 3) . Only the serum hormone and metabolite data were analyzed as a repeated measures-split plot design (Table 5 ). The model included treatment, weight, time, and the interactions. Pig × treatment × weight was the error term. Treatment means were compared by Fisher's least significant difference test.
Results
Final weights for the five treatment groups did differ (Table 2) . That is why they were used as a covariate for the other statistical analyses. Pigs treated with pST were on trial 7 to 8 d fewer ( P < .001) than those not receiving the hormone (Table 2) . This was mainly due to a 14% greater rate of gain ( P < .001).
The pigs treated daily with LPS for 7 d starting at 60 kg BW continued to gain weight, not lose it as was expected, although the LPS-pST group gained only half the weight of the LPS alone treatment group (Table 3) . During the 7 d of LPS injections, ADG was reduced by 75% for PST-treated, 38% for LPS-treated, and 24% for the control pigs compared with growth rates before LPS treatment (all data not shown). Compared with the period before LPS treatment, feed conversion was 64% greater for the control, 206% greater for the LPS-treated, and 327% greater for the pST-treated pigs. The ADG and feed conversion were highly variable and did not differ significantly among treatment groups. Even though the control pigs were not given LPS, the reduction in feed intake due to pair-feeding to the LPS pigs and the stress associated with daily 10-mL injections into the vena cava reduced their growth rate and feed efficiency below those of the 55-kg control pigs. Feed intake was reduced by the endotoxin treatment, especially during the first 2 to 3 d of injections (Figure 1 ). Pigs given LPS alone had recovered 90% of their appetite by the fifth day of treatment. Pigs on the combined LPS-pST treatment never consumed more than 60% of their ration. These differences in feed intake were significantly different from d 2 through the remainder of the week.
Rectal temperatures on d 7 of LPS injection did not differ at 0800, just prior to treatment (Table 3) . However, by 1100 temperatures were progressively elevated ( P < .001). Pigs on the combined LPS-pST treatment had the highest temperatures, and those on LPS alone had temperatures above control values but below those of the pST-treated group.
Heart, liver, and kidney weights, expressed as a percentage of BW (Table 4) , were increased ( P < .001) by pST treatment, both before and after LPS treatment. Pigs treated with LPS had heavier livers and kidneys, expressed as a percentage of BW, Table 2 . Effects of endotoxin treatment and(or) porcine somatotropin on growth performance of growing pigs for the entire treatment period a Treatment groups: CNT, daily i.m. vehicle injected until 55 kg; pST, daily i.m. injected with 100 mg of recombinant porcine somatotropin (pST)/kg BW until 55 kg; LPS-CNT, i.v. saline injected for 1 wk starting at 60 kg BW; LPS, i.v. injected for 1 wk with 1 mg of bacterial lipopolysaccharide (LPS)/kg BW starting at 60 kg; LPS-pST, LPS + pST treatment from 20 kg through LPS treatment.
b Pooled standard error mean; n = 7 for CNT, n = 8 for LPS, LPS-CNT, n = 9 for pST, LPS-pST. c Significant effect at P < .05, TR = treatment effect, W = effect of final weight as a covariate. w,x,y,z Least squares means within a row lacking a common superscript differ ( P < .05). b Pooled standard error mean; n = 8 for LPS, n = 7 for LPS-CNT, and n = 9 for LPS-pST. Growth performance data from one on the LPS-CNT pigs was not used after he was stuck with a needle in the trachea.
c Significant effect at P < .05, TR = treatment effect.
x,y,z Least squares means within a row lacking a common superscript differ ( P < .05). (Table 4 ) was reduced ( P < .001) by pST treatment. After LPS treatment, these backfat measurements were further reduced in the pigs given pST. However, the reduction was significant only at the location of the last lumbar. Treatment with LPS alone had no effect on backfat depth. Longissimus muscle cross-sectional area tended to be greater in the pST-treated pigs, although there was no significant difference.
Protein accretion rates were increased up to 27% by pST treatment, but LPS was without effect ( Figure   2 ). Lipid accretion was reduced 45% by pST treatment in the pigs killed at 55 kg BW. With the addition of LPS treatment, lipid accretion was further reduced by 33% in the pST-treated pigs. The LPS treatment alone had no effect on lipid accretion. Ash accretion rates were not affected by any treatment.
Serum glucose concentrations (Table 5 ) were elevated by pST treatment ( P < .001) in the feeddeprived and fed states at 55 kg BW. After 7 d of LPS injection, neither treatment group had glucose values that differed from those of the controls, although the two treatment groups did differ from each other at 1100. Glucose concentrations were greater at 1100 than at 0800 ( P < .03). Insulin concentrations mimicked the pattern for glucose ( P < .001), except that the pST-induced hyperinsulinemia was present only at 1100 at 55 kg BW. Insulin concentrations were also elevated after feeding ( P < .001).
Somatotropin concentration (Table 5 ) was elevated 3 h after administration ( P < .001) and had not b Pooled standard error mean; n = 7 for CNT, n = 8 for LPS, LPS-CNT, n = 9 for pST, LPS-pST. c Significant effect at P < .05, TR = treatment effect. w,x,y,z Least squares means within a row lacking a common superscript differ ( P < .05). Figure 2 . Carcass component accretion rates (g/d) with final weight as a covariate for all five treatments. The first two bars represent groups started at 20 kg and killed at 55 kg BW. The last three bars represent three groups taken to 60 kg BW and then treated with saline or lipopolysaccharide (LPS) for seven consecutive days. Accretion rates for the last three groups were measured from 20 kg until slaughter after 1 wk of LPS or buffer injections. Least significant means within a carcass component lacking a common letter differ (P < .05). Con or C = control; PGT = porcine somatotropin.
returned to baseline values 24 h later. The LPS treatment had no effect on pST levels. As a mediator of pST action, serum IGF-I concentrations mimicked those of somatotropin, being elevated only in the pigs treated with pST ( P < .001). However, IGF-I levels were lower in all three treatment groups following i.v. injection of LPS or saline ( P < .03). Serum urea nitrogen concentrations were decreased by pST treatment in the feed-deprived and fed states ( P < .001). Levels of SUN were also lower in the feed-deprived state ( P < .001) than after feeding.
Discussion
Growing pigs treated with rpST exhibited typical improvements in growth performance and carcass composition (Campbell et al., 1988; Evock-Clover et al., 1992) . Administration of bacterially derived LPS had no measurable effect on ADG compared with pairfed controls or on carcass lipid or protein accretion rates. Pigs treated with LPS did exhibit a reduction in feed intake, a worsening of feed conversion, and an increase in rectal temperature 3 h after injection. These are all common signs of endotoxin-induced septicemia. Dritz et al. (1996) reported a reduction in ADG and feed intake in 5.0-kg pigs injected i.m. every third day for 18 d with LPS (150 mg/kg BW) relative to non-pair-fed controls. Pigs receiving the combined treatment exhibited an even greater reduction in feed intake and a further increase in rectal temperature over the animals receiving LPS alone. This further increase in hyperthermia was probably due to the increased mass and metabolic activity of the viscera, particularly the liver, induced by pST administration (Noblet et al., 1992) combined with the pyrogenic effects of LPS treatment. This further elevation in body temperature in the pST-LPS pigs could be beneficial in fighting many bacterial infections. Green and Vermeulen (1994) reported that elevated temperatures (41°C ) prevent Gram-negative bacteria from synthesizing their protective LPS coat in vitro, thereby enabling the host defense systems to perforate and kill the invading pathogens, even prior to the production of host antibodies. Table 5 . Effects of endotoxin treatment and(or) porcine somatotropin on serum hormones and metabolites of growing pigs a Treatment groups: LPS-CNT, i.v. saline-injected for 1 wk starting at 60 kg BW; LPS, i.v. injected for 1 wk with 1 mg bacterial lipopolysaccharide (LPS)/kg BW starting at 60 kg; LPS-pST, LPS + porcine somatotropin(pST) treatment from 20 kg through LPS treatment.
b Pooled standard error mean over all treatments, weights, and times; n = 8 for LPS, LPS-CNT, n = 9 for LPS-pST. c Significant effect at P < .05, TR = treatment effect, W = weight effect, T = time effect. v,w,x,y,z Least squares means within a row lacking a common superscript differ ( P < .05). Pigs on the combined treatment also exhibited a significant reduction in carcass lipid accretion and in backfat thickness measured at the last lumbar, compared with pigs on pST alone. These data suggest that the existing lipid stores already present by 55 kg BW in these pST-treated pigs were reduced by the 7 d of endotoxin treatment. It cannot be stated with certainty whether this lipid mobilization was due to the reduced feed intake, the high fever, or a combination of other immune responses, in addition to the direct contribution from the continued administration of pST. Pigs weighing 12 kg treated with 5 mg of LPS/ kg BW exhibited a 10-fold increase in TNF-a and a 100-fold increase in interleukin(IL)-6 2 h after injection (Finck et al., 1996) . Both TNF-a and IL-6 have been shown to induce proteolysis and lipolysis in other species. However, cattle treated with somatotropin demonstrated reduced production of TNF-a following in vivo administration of bacterially derived endotoxin (Elsasser et al., 1994) .
Thymus weights of all the LPS-treated and LPScontrol pigs were lower than in the control pigs killed at 55 kg. Likewise, thymus weights obtained from the pST-treated pigs after LPS administration were less than those of the pST-treated pigs killed at 55 kg BW. Thymus weight, as a percentage of BW, tended to be higher in the pST-treated pigs, although it was not a significant difference. Wise et al. (1994) reported a dose-dependent increase in thymic weights in pigs treated with pST. Treatment of intact rodents with either recombinant human ( rh) ST (Yakar et al., 1994) or IGF-I (Clark et al., 1993) caused enlargement of the spleen and thymus glands. In pigs, longterm treatment with recombinant pST at a dose of 5 mg/d also resulted in higher spleen weights (Goff et al., 1991) relative to controls. Higher doses of pST, however, were without effect. In the present experiment, spleen weights were not affected by either LPS or pST treatment alone. However, pigs given both treatments did exhibit an enlargement of the spleen. Wise et al. (1996) also found no change in spleen weights with pST treatment alone. These results are not surprising because LPS is known as a thymusindependent antigen and can stimulate B lymphocytes directly to produce antibodies. Additionally, mice transgenic for the rat metallothionein-somatotropin gene exhibited enhanced proliferation of splenocytes in response to certain mitogens, but not in the unstimulated state (Davila et al., 1987) . LeRoith et al. (1996) also observed an increase in the percentage of B lymphocytes in the spleen and an increased antibody titer to tetanus toxoid in monkeys treated daily with 100 mg of rhST/kg BW for 7 wk.
Pigs treated with pST had the typical responses of hyperinsulinemia and hyperglycemia prior to administration of LPS. After 7 d of LPS injection in addition to pST treatment, these effects were negated. Treatment with LPS alone did not alter serum glucose or insulin concentrations. Finck et al. (1996) also reported no effect of LPS treatment on serum glucose concentrations in 12-kg pigs treated with 5 mg LPS/kg BW. They did not measure insulin concentrations.
Pigs injected with pST exhibited large increases in serum growth hormone and IGF-I concentrations. Typically, pST concentrations return to baseline levels by 24 h after injection; however, they were still above control values at that time in this experiment. This could be due to a different construct of the recombinant pST used in this experiment. Southern Cross recombinant pST has the same amino acid sequence as native pST except for an additional methionine at the N terminal. Treatment with LPS had no significant effect on serum ST or IGF-I concentrations, even though the hormone concentrations tended to be less 3 h after in vivo LPS treatment than they had been at the same time at 55 kg BW. Matteri et al. (1996) also reported a suppression of pST concentrations in neonates at 21 and 28 d of age after i.p. administration of 150 mg LPS/kg BW. However, they suggested that this did not reflect a suppression of overall pituitary function.
Urea nitrogen concentrations were reduced by pST treatment. Administration of LPS did not affect BUN levels at the time points measured in this experiment. Finck et al. (1996) reported a two-to threefold increase in BUN at 8 and 12 h after LPS injection ( 5 (g/kg BW) in 12-kg pigs. They also saw no effect at 2, 4, or 24 h after LPS administration. Their data would indicate an increase in muscle catabolism, although they used a fourfold greater dose of LPS. Protein accretion rates in our experiment did not indicate a significant effect of LPS treatment, although the rate was slightly lower after LPS than at 55 kg BW.
Implications
The observed responses to porcine somatotropin and a subsequent endotoxin-induced immune challenge in pigs are novel and potentially important, should somatotropin become approved for use in the swine industry. Treatment with porcine somatotropin did not negate the overall response to an endotoxin challenge, but it did not enhance any clearly harmful responses. However, feed intake during the 7-d endotoxin treatment of pigs also treated with somatotropin was suppressed. Unfortunately, we cannot speculate on how somatotropin treatment might have affected the recovery from endotoxin treatment because the pigs were slaughtered after the week of endotoxin treatment.
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